TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo

Journal of Clinical Investigation · Published 2026-08-02 · DOI 10.1172/jci194449

Free full text

Authors (25)

Shahrzad Jalali, Sekar Natesampillai, Zilin Nie, Ying Zhang, Ismail Can, Aswath P. Chandrasekar, Brianna M. Hameister, Cristina Correia, Tuantuan V. Zhao, Dong-Gi Mun, Enrique Garcia-Rivera, Robert Matson, Ashton Krogman, Mark A. Maynes, Robin Batchelor, Dileep D. Monie, Hu Li, Atta Behfar, Saad S. Kenderian, Akhilesh Pandey, Stephen M. Ansell, Timucin Taner, Cornelia Weyand, Daniel D. Billadeau, Andrew D. Badley

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Jalali, S., Natesampillai, S., Nie, Z., et al. (2026). TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo. Journal of Clinical Investigation. https://doi.org/10.1172/jci194449

Related articles

• A peripheral subpopulation of retinal pigment epithelium resists oxidative damage through SERPINE3-mediated Caspase-1 inhibition · Journal of Clinical Investigation · 2026 · Same journal
• Sterol biosynthesis, brain development, and disease · Journal of Clinical Investigation · 2026 · Same journal
• S100A11 regulates hepatic cholesterol metabolism and promotes steatohepatitis via non-canonical SREBP2 signaling · Journal of Clinical Investigation · 2026 · Same journal
• Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment · Journal of Clinical Investigation · 2026 · Same journal
• Protein neddylation as a therapeutic target: challenges and opportunities · Journal of Clinical Investigation · 2026 · Same journal
• Diabetic and ER-stressed pancreatic islet β cells are in need of some JNK removal · Journal of Clinical Investigation · 2026 · Same journal
• Winners of Lasker Foundation Video Contest announced · Journal of Clinical Investigation · 2026 · Same journal
• The bone-cerebrovascular axis: effects of bone aging on neurovascular dysfunction and neurodegeneration · Journal of Clinical Investigation · 2026 · Same journal
• Histone lysine methyltransferases KMT2C and KMT2D join the all-star tumor suppressor team in gastrointestinal cancer · Journal of Clinical Investigation · 2026 · Same journal
• Arul M. Chinnaiyan, MD, PhD, and Charles L. Sawyers, MD, receive the 2026 Harrington Prize for Innovation in Medicine · Journal of Clinical Investigation · 2026 · Same journal